Pillar’s oncoReveal Essential+ assay has been validated at LSI Medience for cfDNA and cfRNA screening, with the project expected to include about 2,000 lung cancer patients over two years....
The acquisition brings HMI Medical’s diagnostic and imaging network to seven centres, expanding access to MRI, CT and subspecialty radiology services across Singapore....
The 360-patient study showed statistically significant improvement in 90-day functional outcomes, with no investigational drug-related serious adverse events reported....
The reusable clip sensor recorded an Accuracy Root Mean Square value of 1.6% in desaturation studies and is designed to improve pulse oximetry consistency....
Greater access to genomic testing, local population data and real-world evidence will be central to widening the clinical use of liquid biopsy and precision medicine across Asian healthcare systems....
The i-SIGHT2 pivotal trial is evaluating a noninvasive office-based bioelectric therapy for intermediate to advanced dry age-related macular degeneration. ...
The clearance expands the LifeLens Physiological Monitor beyond ECG acquisition to include respiratory, temperature, activity and gait parameters. ...
SOMNUM V3.0 supports automated analysis of polysomnography data and classifies obstructive, central and mixed sleep apnea events....
The company is preparing a dual FDA 510(k) and CLIA Waiver submission for its Flu A/B and RSV multiplex test on the Co-Dx PCR Pro platform....
The launch includes AgeQ, a first-in-market biological age clinical assessment designed to provide early insights and guidance for healthier ageing....
